Sam Altman’s $180 million anti-ageing bet: The bold longevity plan to fight ageing and extend human lifespan |
For years, Silicon Valley treated ageing as a background fact of life rather than a technical problem. Wealth from the AI boom is now flowing into laboratories studying cells, proteins, and human lifespan, with some of the technology industry’s biggest names placing unusually large bets on medicine. Among them is Sam Altman, whose backing of…